Prognostic significance of plasma interleukin-6/-8 in pancreatic cancer patients receiving chemoimmunotherapy

doi:10.3748/wjg.v21.i39.11168

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 21, Issue 39

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8604)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series, Tables (1-2) series.

Item

Count

PDF

511

WORD

270

HTML

4264

Figures (1-6)

256

Tables (1-2)

428

Sum=5729

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1091

Download

1784

Sum=2875

Oct 21, 2015 (publication date) through Mar 10, 2025

Times Cited of This Article

Times Cited (23)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Trials Study

World J Gastroenterol. Oct 21, 2015; 21(39): 11168-11178
Published online Oct 21, 2015. doi: 10.3748/wjg.v21.i39.11168

Table 2 Wilms’ tumor 1-specific delayed-type hypersensitivity reactions

Patient	Gemcitabine		*HLA-A02:01**											*HLA-A24:02**											HLA-DRB1/DPB1
No.	Vaccine times											Vaccine times											Vaccine times
	Pre	Post	1	5	10	15	20	25	30	35	40	45	70	1	5	10	15	20	25	30	35	40	45	70	1	5	10	15	20	25	30	35	40	45	70
1	-	-	+	+	++	++	++	++	+	-	ND			+	+	++	++	++	++	+	-	ND			+	+	++	++	++	++	+	-	ND
2	-	-	-	-	-	-	-	-	-	-	-	-	ND	+	+	++	++	+	+	+	+	+	-	ND	+	+	++	++	+	+	+	+	+	-	ND
3	-	-	-	-	ND									-	-	ND									-	-	ND
4	-	-	-	-	ND									-	-	ND									-	-	ND
5	-	-	-	-	-	ND								-	-	-	ND								-	-	-	ND
6	-	-	-	-	-	-	-	-	-	-	-	-	-	+	+	++	++	++	++	++	++	++	++	++	+	+	++	++	++	++	++	++	++	++	++
7	-	-	-	-	-	-	-	ND						-	-	+	+	-	ND							-	+	+	-	ND

Delayed-type hypersensitivity (DTH) erythema < 1 mm, +; DTH erythema 2-5 mm, ++; DTH erythema > 5 mm, not done (ND).

Citation: Tsukinaga S, Kajihara M, Takakura K, Ito Z, Kanai T, Saito K, Takami S, Kobayashi H, Matsumoto Y, Odahara S, Uchiyama K, Arakawa H, Okamoto M, Sugiyama H, Sumiyama K, Ohkusa T, Koido S. Prognostic significance of plasma interleukin-6/-8 in pancreatic cancer patients receiving chemoimmunotherapy. World J Gastroenterol 2015; 21(39): 11168-11178
URL: https://www.wjgnet.com/1007-9327/full/v21/i39/11168.htm
DOI: https://dx.doi.org/10.3748/wjg.v21.i39.11168